Sematilide. CK 1752, CK 1752A, ZK 110516.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004285:Dogs; D004347:Drug Interactions; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D026902:Potassium Channel Blockers; D011342:Procainamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats
D000889:Anti-Arrhythmia Agents; D015507:Drugs, Investigational; D026902:Potassium Channel Blockers; C062818:sematilide; D011342:Procainamide